Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor
Not Applicable
Completed
- Conditions
- Chronic Leukemia
- Interventions
- Other: Additional biological samples
- First Posted Date
- 2016-07-22
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 120
- Registration Number
- NCT02842333
- Locations
- 🇫🇷
Hôpital Saint-Louis, Paris, France
🇫🇷Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
🇫🇷CHU de Nice, Nice, France
Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies.
Not Applicable
Completed
- Conditions
- EthicsAdvanced Cancer
- Interventions
- Other: interviews
- First Posted Date
- 2016-07-22
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 21
- Registration Number
- NCT02841124
- Locations
- 🇫🇷
Centre Hospitalier de Colmar, Colmar, France
🇫🇷Centre Hospitalier Universitaire St Antoine, Paris, France
🇫🇷Centre de Luttre Contre le Cancer Alexis Vautrin, Vandœuvre-lès-Nancy, France
Old Red Blood Cell In Renal Transplantation
Completed
- Conditions
- Transfusion ReactionDisorder Related to Renal Transplantation
- First Posted Date
- 2016-07-22
- Last Posted Date
- 2016-07-22
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 12000
- Registration Number
- NCT02841111
Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients
Not Applicable
- Conditions
- Alzheimer DiseaseDepression
- Interventions
- Device: high-density electroencephalography
- First Posted Date
- 2016-07-21
- Last Posted Date
- 2017-08-09
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 30
- Registration Number
- NCT02840045
- Locations
- 🇫🇷
CHRU Besançon, Besancon, Franche-Comte, France
Biochip for HCMV Detection in Breast Milk
Terminated
- Conditions
- Premature Birth of NewbornCytomegalovirus InfectionsBreast Feeding
- First Posted Date
- 2016-07-21
- Last Posted Date
- 2022-07-28
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 2
- Registration Number
- NCT02840825
- Locations
- 🇫🇷
CHRU de Besançon, Besançon, France
Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1
Not Applicable
- Conditions
- Cancer
- Interventions
- Other: Biological samplesDrug: Anti PD1/PDL1 treatment
- First Posted Date
- 2016-07-21
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 120
- Registration Number
- NCT02840058
- Locations
- 🇫🇷
University Hospital of Besançon, Besancon, France
Study of Anti-telomerase T CD4 Immunity in Melanoma
Not Applicable
- Conditions
- Melanoma
- Interventions
- Other: biological samples
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 200
- Registration Number
- NCT02838433
- Locations
- 🇫🇷
Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors
Phase 2
Completed
- Conditions
- Neuroendocrine Tumors
- Interventions
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 28
- Registration Number
- NCT02838342
- Locations
- 🇫🇷
Centre Hospitalier Universitaire de Besançon, Besancon, France
🇫🇷Hôpital Nord Franche-Comté, Montbéliard, France
Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life
Not Applicable
Active, not recruiting
- Conditions
- Tumor With Bone Metastasis
- Interventions
- Other: quality of life questionariesDrug: intravenous or oral bone antiresorptive treatments
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 148
- Registration Number
- NCT02839291
- Locations
- 🇫🇷
Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
🇫🇷Hôpital Nord Franche-Comté, Montbéliard, France
Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases
Not Applicable
Completed
- Conditions
- Inflammation
- Interventions
- Biological: Blood sample
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 150
- Registration Number
- NCT02839278
- Locations
- 🇫🇷
University Hospital, Besançon, France
© Copyright 2025. All Rights Reserved by MedPath